<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5470933A-F878-4AAB-BE6C-BF4267FC8A10"><gtr:id>5470933A-F878-4AAB-BE6C-BF4267FC8A10</gtr:id><gtr:name>Rutgers State University of New Jersey</gtr:name><gtr:address><gtr:line1>249 University Ave</gtr:line1><gtr:line4>New Brunswick</gtr:line4><gtr:line5>NJ 08901</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1CE7684B-44CA-403E-B166-3EDE5F43FC9F"><gtr:id>1CE7684B-44CA-403E-B166-3EDE5F43FC9F</gtr:id><gtr:name>Department for Culture, Media and Sport (DCMS)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522"><gtr:id>4D0DCB45-3ED8-494B-8C55-B5E8DF9DB522</gtr:id><gtr:name>UNLISTED</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C938B173-5DDC-45B5-99C4-2516368FAD32"><gtr:id>C938B173-5DDC-45B5-99C4-2516368FAD32</gtr:id><gtr:name>Public Health England (formerly: Health Protection Agency)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5470933A-F878-4AAB-BE6C-BF4267FC8A10"><gtr:id>5470933A-F878-4AAB-BE6C-BF4267FC8A10</gtr:id><gtr:name>Rutgers State University of New Jersey</gtr:name><gtr:address><gtr:line1>249 University Ave</gtr:line1><gtr:line4>New Brunswick</gtr:line4><gtr:line5>NJ 08901</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1CE7684B-44CA-403E-B166-3EDE5F43FC9F"><gtr:id>1CE7684B-44CA-403E-B166-3EDE5F43FC9F</gtr:id><gtr:name>Department for Culture, Media and Sport (DCMS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/025E23FD-0EC9-493D-A5D8-0C78AF12EA35"><gtr:id>025E23FD-0EC9-493D-A5D8-0C78AF12EA35</gtr:id><gtr:firstName>Julia</gtr:firstName><gtr:surname>Gorelik</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1205F48B-53ED-48DE-8561-E46FA8C97DDC"><gtr:id>1205F48B-53ED-48DE-8561-E46FA8C97DDC</gtr:id><gtr:firstName>Teresa Dorothy</gtr:firstName><gtr:surname>Tetley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/385B2395-CCBE-4E64-9EE0-06682FF3FEE1"><gtr:id>385B2395-CCBE-4E64-9EE0-06682FF3FEE1</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>de Mello</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D036A9E3-3DF1-4344-AC52-DFFE71FF21F3"><gtr:id>D036A9E3-3DF1-4344-AC52-DFFE71FF21F3</gtr:id><gtr:firstName>Milo</gtr:firstName><gtr:surname>Shaffer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A4B7208A-B5B4-4848-AC20-0CA2C587E181"><gtr:id>A4B7208A-B5B4-4848-AC20-0CA2C587E181</gtr:id><gtr:firstName>Yuri</gtr:firstName><gtr:surname>Korchev</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700926"><gtr:id>9FC1E3BF-4075-4137-9C16-DCDFB00B9BFC</gtr:id><gtr:title>Mechanisms of bioreactivity of engineered nanoparticles with pulmonary gas exchange barrier</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700926</gtr:grantReference><gtr:abstractText>Nanotechnology is a rapidly emerging area of science involving synthesis of engineered nanoparticles that are less that the width of a hair (ie less than 100 nanometres in size). Nanoparticles are processed to form larger products which are not harmful; they are used in engineering, medicine, cosmetics and many other day-to-day products. Nanoparticles have unique properties which make them very attractive and useful in producing new products; however, the properties that make them unique may unfortunately have health effects. We know very little about the hazards or risks associated with exposure to these materials because they are so new. As nanotechnology is moving so fast it is important to establish whether nanoparticles are likely to be toxic or to have unwanted health or environmental effects. If we know this we can protect people and the environment from exposure. We know that when susceptible individuals are exposed to high levels of air pollution which contains nano-sized particles they may develop heart and lung problems and have to go to hospital and might even die. This suggests that inhalation of very small, nanosized engineered particles might cause heart and lung problems, although they have very different properties to air pollution particles. The aim is to discover whether inhaled engineered nanoparticles are harmful and whether they cause breathing or heart problems if they reach the delicate air sacs of the lung. We will use cells that line human lungs and the blood vessels of the lung. These cells will be exposed to the nanoparticles to discover whether the they are toxic and if so, how toxic and why? Do the exposed cells release molecules that might cause inflammation or blood clotting? We want to know what properties of the particles make them dangerous - are they sharp, or do they pass into the cells, or between the cells or are any particular surface chemicals responsible for nanoparticle toxicity? We will watch nanoparticles under a unique microscope to see how they alter cell behaviour. We hope to learn whether inhaled, engineered nanoparticles are likely to be harmful. If they are, is it possible to make particles that are not harmful? This information will allow us to provide guidelines on the possible risks of inhaling engineered nanoparticles, as well as preventing exposure, particularly at work, where levels may be high.</gtr:abstractText><gtr:technicalSummary>There has been a rapid emergence and expansion of nanotechnology - hundreds of products utilise nanoparticles. Unfortunately, the properties that make nanomaterials so attractive for use eg in electronics, cosmetics, textiles and medicine may have negative health effects. There are serious, urgent concerns that research on possible toxicity and risk of nano- sized materials to human health is insufficient compared to their current rate of production and use; recent reports describe the situation as urgent. Epidemiological studies of particulate air pollution suggest that inhalation of high levels of nano-sized particles causes increased cardiorespiratory morbidity and mortality, particularly in those with existing disease. This may be because the alveolar units are easily accessible by inhaled nano-sized particles ( 100nm), and delivery of large numbers (but low mass) of nanosized particles, with a large reactive surface area, to the alveolar epithelial-endothelial barrier of the lung may elicit pulmonary inflammation, release of pro-thrombotic factors and facilitate particle translocation into the vasculature. We hypothesise that the degree of bioreactivity and translocation of inhaled nanoparticles at the alveolar epithelial-endothelial blood-gas barrier depends on the physicochemical properties of the particles and nature/response of the target cell. In this cross-disciplinary study, materials scientists, a lung cell biologist, a cardiovascular cell biologist and biophysicist will collaborate to address this hypothesis. Materials scientists will synthesise and fully characterise a series of designer nanoparticles initially using silver and titanium dioxide, as well as carbon nanotubes. These particles have been chosen because their production and use is increasing fast; other particles may be used depending on the early findings. The chemists can strictly control nanoparticle synthesis and functionalisation for in vitro studies. Primary human pulmonary alveolar epithelial cells, capillary endothelial cells as well as monocyte-derived macrophages and dendritic cells will be exposed to the particles in both monoculture and co-culture to represent the alveolar-endothelial membrane in vivo. Effects will be assessed using conventional toxicology as well as determining more subtle molecular-biochemical changes, mechanisms of particle internalisation and intracellular localisation. Living cells will be examined at the level of the electron microscope by scanning ion conductance microscopy and scanning surface confocal microscopy to discover the exact features controlling particle uptake and how particles might affect the integrity of the epithelial-endothelial barrier. Any effects of test particles will be related to their physicochemistry and functionalisation to establish possible patterns or trends that predict reactivity or non-reactivity which will help in determining risk factors.</gtr:technicalSummary><gtr:fund><gtr:end>2011-08-17</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-08-18</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>642791</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Identification of mechanisms of platelet activation by nano-particle pollutants in the UK</gtr:description><gtr:id>8135A43F-3162-41EA-8814-878623ED680F</gtr:id><gtr:impact>One publication.</gtr:impact><gtr:partnerContribution>Knowledge of the cardiovascular system and measurement of platelet activation</gtr:partnerContribution><gtr:piContribution>Lung cell biology, knowledge of role of inhaled particulate air pollution in cardiorespiratory disease, working with nanoparticles</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southern California</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Respiratory effects of silver and carbon nanomaterials (RESAC)</gtr:description><gtr:id>E650B458-6FE2-48A4-BA21-ABE3274075B9</gtr:id><gtr:impact>This is a very recent collaboration which was funded end of September 2010. We will be working with modellers, epidemiologists, experts in lung surfactant biology, immunology and oxidative stress to complement the imperial College expertise in cell biology, in vivo models of lung disease and materials science.</gtr:impact><gtr:partnerContribution>The collaborators have experience in modelling, in lung surfactant biology and in oxidative stress that will add to the research programme in my laboratory.</gtr:partnerContribution><gtr:piContribution>I am the UK PI on this study and the working hypothesis was proposed by me. I co-ordinated all the UK applicants and integrated the core research (materials scientists) with the 3 research WPs. I was responsible for writing 2 of the 3 WPs. We have set up unique in vitro models of the human lung, we can establish well-characterised in vivo models to study lung surfactant metabolism, we work closely with the material scientists and use unique imaging methods to study particle-cell interactions.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department for Culture, Media and Sport (DCMS)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Natural History Museum</gtr:department><gtr:description>NanoRetox programme</gtr:description><gtr:id>404E3F70-0DA4-46B2-B04E-DC5C591E8717</gtr:id><gtr:impact>We have, between us, obtained over ten million pounds worth of funding from the UK, EU and US agencies. Those involving me have been listed. These studies involve cell biologists, materials scientists, chemists, physicists, aerosol scientists, clinicians, epidemiologists.</gtr:impact><gtr:partnerContribution>We have set up NaNoRISK, Nanotoxicology Research In South Kensington. This facilitates collaborative, multidisciplinary research between the instutions and has provided a platform from which to obtain funding.</gtr:partnerContribution><gtr:piContribution>Our expertise with primary human lung cells and our long experience studying environmental toxicants in experimental models in vitro and in vivo.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Engineering</gtr:department><gtr:description>The cytoxicity of carbon nanostructures to lung epithelial cells: The effect of aspect ratio and surface functionalisation</gtr:description><gtr:id>E8EFF744-6312-4969-B33B-E9340BC95EE0</gtr:id><gtr:impact>I am a cell biologist, one partner is a chemist, the other is a materials scientist.</gtr:impact><gtr:partnerContribution>The Materials scientists are synthesising the carbon nanotubes in specific formats. The interaction of these nanomaterials with the lung cells are being studied using state of the art electron microscopy (Titan) and other analytical techniques</gtr:partnerContribution><gtr:piContribution>I am the lung cell biologist, providing expertise with human lung cell models in vitro, knowledge of the lung and analysis of the exposure models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England (formerly: Health Protection Agency)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Radiation, Chemicals and Environmental Hazards (CRCE)</gtr:department><gtr:description>Exposure of experimental animals to aerosolised nanoparticulates</gtr:description><gtr:id>0DA83CFA-13E3-43C6-B030-AF40C6CAD977</gtr:id><gtr:impact>The inhalation studies in RAMNUC and RESAC will not start until late 2011. This collaboration involves aerosol scientists, physicists, pathologists, cell biologists, material scientists and chemists.</gtr:impact><gtr:partnerContribution>The agency has uniqure inhalation facilities which have been established by experts in aerosol science who will set up the facility, advise on exposure protocols and will perform the exposures and lung function studies. Although there is no direct funding through this collaboration, sections of two grants, RAMNUC and RESAC, include in vivo exposures to be carried out at the HPA which we believe proved attractive to the reviewers.</gtr:partnerContribution><gtr:piContribution>We will be performing the cellular/molecular analyses. The material scientists associated with this research will provide the nanoparticles.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>Nanoparticles, sensory irritation and the lung: environmental influences on biological processes</gtr:description><gtr:id>8D5364E1-9105-4E91-8D4B-8C626D3E62C3</gtr:id><gtr:impact>None yet. Brings together a materials scientist, a pharmacologist and lung cell biologist</gtr:impact><gtr:partnerContribution>One partner works on the vagus nerve model and cough, the other is an expert in imaging.</gtr:partnerContribution><gtr:piContribution>I am providing the nanoparticle expertise and analytical techniques</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Rutgers University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Risk Assessment for Manufactured Nanoparticles Used in Consumer Products (RAMNUC)</gtr:description><gtr:id>0939F855-8D69-4A29-9157-EFE9FE4B5EDF</gtr:id><gtr:impact>We started this research this year and there aree no outputs/outcomes as yet. The research is multidisciplinary, involving cell biologists, clinicians, epidemiologists, modellers, aerosol scientists and material scientists.</gtr:impact><gtr:partnerContribution>We have links with modellers to investigate the possible environmental and other risks associated with exposure to ZnO and Ag nanomaterials that are being used in commercial products. Specifally to study nanoparticles' life cycle: (1) sources, (2) environmental fate and transport, (3) concentrations in environmental media, (4) human exposure, (5) dose at target organs and bioavailability, (6) toxicological effects, and (7) ecological impacts. In addition, access to immune in vitro models of human monocytes and macrophages to investigate susceptibility to TB in the presence of nanoparticles. The combined expertise allows us to examine and understand better the impact of these nanopartoicles throughout their lifespan and therefore to predict hazard and risk.</gtr:partnerContribution><gtr:piContribution>I am a co-PI of the grant. I brought together all the PIs from the UK consortium (material scientists, the collaborators at the HPA inhalation facility, the in vivo scientist) and wrote a significant portion of the work packages for the in vitro and in vivo studies. I will be the PI for the in vitro work package (WP1), reflecting my group's expertise with primary human lung cells in vitro and models to assessnanoparticle reactivity.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Breathing Easy</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4540D943-0EA4-452F-A69A-9D1B9EBFE54E</gtr:id><gtr:impact>The lecture theatre at the Royal Instuitute was full (200?) of schoolchildren between 8 and 12 years. They were very excited at some of the demonstrations and asked lots of questions. They alos came to talk to me afterwards, as did their parents/teachers..

I did not get any feedback; perhaps the RI did.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Nanoparticles effects on cell membranes and function - programme grant/Naional Institute for Environmentyal Health, US</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>NIEHS No. U19ES019536</gtr:fundingRef><gtr:id>ED9A6BBB-B73F-4CE9-9933-7642476191AF</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Nanoparticles, sensory irritation and the lung: environmental influences on biological processes.</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>EFE0C64E-A406-46EE-A347-E8EFA3EE3827</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Brompton NHS Trust PhD studentship</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Royal Brompton &amp; Harefield NHS Foundation Trust</gtr:fundingOrg><gtr:id>DB9A8D7D-F99E-4E06-A037-B6F09D8C3F06</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel award</gtr:description><gtr:end>2009-05-02</gtr:end><gtr:fundingOrg>British Lung Foundation (BLF)</gtr:fundingOrg><gtr:id>B4D0B87D-D6F4-4F9B-B32F-23B3B32122AF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD Studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Unilever</gtr:fundingOrg><gtr:id>3D405DC5-8554-4CEA-BA37-0280673CDC44</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>PhD studentship National Heart &amp;amp; Lung Institute</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Imperial College London (ICL)</gtr:fundingOrg><gtr:id>97751B91-4B44-4F1C-AB5B-F1AB930A678F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel award</gtr:description><gtr:end>2007-05-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>B47B88EB-0EAF-4D4D-8E47-D78E3450F346</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC-HPA Center PhD studentship</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3CE15047-8266-4057-8461-30E0890D00F9</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>340</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel award</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>European Respiratory Society (ERS)</gtr:fundingOrg><gtr:id>221E82C1-6160-4C41-BA21-4D4E18D8A1C4</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>4ED48D61-6F25-45D5-AD01-0852E00D886D</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel award NanoImpact EU</gtr:description><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>8C931BA3-A0F6-43AF-81B0-9CEF11A0118D</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Public Health England (formerly: Health Protection Agency)</gtr:fundingOrg><gtr:id>4C18F25D-A67B-47F8-88C5-51FA3F007AC0</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel award NanImpactNet EU</gtr:description><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>252C4DCF-1FC4-403E-AD3D-27C179C6D1EE</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel award NanoImpactnet EU</gtr:description><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>D957ED2D-2501-4A8B-801E-C0D147285D22</gtr:id><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NE/H012893/1 Risk Assessment for Manufactured Nanoparticles Used in Consumer Products (RAMNUC) (&amp;pound;1.4m shared between T Lee, P Elliott and T Tetley</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Natural Environment Research Council (NERC)</gtr:fundingOrg><gtr:fundingRef>NE/H012893/1</gtr:fundingRef><gtr:id>D8443F39-9A4A-48B9-8222-D948F24C747B</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RCUK Fellowship</gtr:description><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>6E14DCDF-4633-4F77-BF25-B02A93B30CBD</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>437500</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7 Programme</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Community Research and Development Information Service (CORDIS)</gtr:fundingOrg><gtr:id>DC4F986F-E6C5-42C5-AF7A-A28C670F6080</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Nanotoxicology Research Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D820ADC3-F148-4E80-AB7F-89F76A17FE3A</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The work in this project was the start of examining exactly how inhaled nanomaterials would interact with the alveolar epithelium and translocate into the pulmonary interstitium or possibly the vasculature. Very exact mechanisms have been identified, including punching holes into the epithelium and active processes involving clathrin. a small percentage (3%) of particles have been shown to translocate to the basal compartment.</gtr:description><gtr:id>81351D19-EFFE-4FC9-B591-DA78EA28BD25</gtr:id><gtr:impact>This research tool allows for very accurate determinstion of the uptake and translocation of nanosized objects through human respiratory epithelium.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>In vitro models of human respiratory unit</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:url>http://pubs.acs.org/doi/abs/10.1021/nn505399e</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5368E722-23A8-4AC2-927D-1D3698603E67"><gtr:id>5368E722-23A8-4AC2-927D-1D3698603E67</gtr:id><gtr:title>Functional interaction between charged nanoparticles and cardiac tissue: a new paradigm for cardiac arrhythmia?</gtr:title><gtr:parentPublicationTitle>Nanomedicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9ae560fb278bfe830b1b641c64a543d4"><gtr:id>9ae560fb278bfe830b1b641c64a543d4</gtr:id><gtr:otherNames>Miragoli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1743-5889</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA44074F-3865-4E4B-BCD1-36074DDFE5CE"><gtr:id>DA44074F-3865-4E4B-BCD1-36074DDFE5CE</gtr:id><gtr:title>Modeling in vitro cellular responses to silver nanoparticles.</gtr:title><gtr:parentPublicationTitle>Journal of toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bef9b69a60d1340ef613abc598cd2e97"><gtr:id>bef9b69a60d1340ef613abc598cd2e97</gtr:id><gtr:otherNames>Mukherjee D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1687-8191</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7CB7B929-FB5C-4944-990F-1D1B9CCADA52"><gtr:id>7CB7B929-FB5C-4944-990F-1D1B9CCADA52</gtr:id><gtr:title>An alternative mechanism of clathrin-coated pit closure revealed by ion conductance microscopy.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b81bfd8be779cf900404a0ebc9832138"><gtr:id>b81bfd8be779cf900404a0ebc9832138</gtr:id><gtr:otherNames>Shevchuk AI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/479A199D-6F7E-4FDB-9EC2-22721616283E"><gtr:id>479A199D-6F7E-4FDB-9EC2-22721616283E</gtr:id><gtr:title>Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6361347641afdfb1b32fe7c74d64b9b0"><gtr:id>6361347641afdfb1b32fe7c74d64b9b0</gtr:id><gtr:otherNames>McKenzie Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/899158CB-77D2-4FBE-A86F-2EA0E805CA41"><gtr:id>899158CB-77D2-4FBE-A86F-2EA0E805CA41</gtr:id><gtr:title>Impacts of a nanosized ceria additive on diesel engine emissions of particulate and gaseous pollutants.</gtr:title><gtr:parentPublicationTitle>Environmental science &amp; technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f5ff2310b21823fdc45326aba6a7d2d"><gtr:id>6f5ff2310b21823fdc45326aba6a7d2d</gtr:id><gtr:otherNames>Zhang J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-936X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/034FF468-541B-4558-9D10-D16DCB497515"><gtr:id>034FF468-541B-4558-9D10-D16DCB497515</gtr:id><gtr:title>The stability of silver nanoparticles in a model of pulmonary surfactant.</gtr:title><gtr:parentPublicationTitle>Environmental science &amp; technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9a526ade75fb88ebaf6b4c4419688b83"><gtr:id>9a526ade75fb88ebaf6b4c4419688b83</gtr:id><gtr:otherNames>Leo BF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-936X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7114AF9A-4D02-4C87-9957-731F056B7EA2"><gtr:id>7114AF9A-4D02-4C87-9957-731F056B7EA2</gtr:id><gtr:title>Type 1 pulmonary epithelial cells: a new compartment involved in the slow phase of particle clearance from alveoli.</gtr:title><gtr:parentPublicationTitle>Nanotoxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f533f622b5f86d8f9006a0e173952ed"><gtr:id>7f533f622b5f86d8f9006a0e173952ed</gtr:id><gtr:otherNames>Maynard RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1743-5390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA2A4F88-9F16-4649-8989-F1745E62D63D"><gtr:id>BA2A4F88-9F16-4649-8989-F1745E62D63D</gtr:id><gtr:title>Translocation of Functionalized Multi-Walled Carbon Nanotubes across Human Pulmonary Alveolar Epithelium: Dominant Role of Epithelial Type 1 Cells.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b37247973055fb50f821ed3fbcf1cdff"><gtr:id>b37247973055fb50f821ed3fbcf1cdff</gtr:id><gtr:otherNames>Ruenraroengsak P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5FB0402E-49C1-4DFF-B341-7C839516A665"><gtr:id>5FB0402E-49C1-4DFF-B341-7C839516A665</gtr:id><gtr:title>Expression of blood dendritic cell antigens (BDCAs) by CD1a+ human pulmonary cells.</gtr:title><gtr:parentPublicationTitle>Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c948227879871f6d442f2fe09ec1e1e0"><gtr:id>c948227879871f6d442f2fe09ec1e1e0</gtr:id><gtr:otherNames>Tsoumakidou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-6111</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EADB3B83-5704-4C18-A3EE-6C2FFC7D4B1A"><gtr:id>EADB3B83-5704-4C18-A3EE-6C2FFC7D4B1A</gtr:id><gtr:title>Sulfidation of silver nanowires inside human alveolar epithelial cells: a potential detoxification mechanism.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1661961c3e118f7f4e3b8856f64cecee"><gtr:id>1661961c3e118f7f4e3b8856f64cecee</gtr:id><gtr:otherNames>Chen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31819F3B-A027-452F-B1CC-19A5D26532E6"><gtr:id>31819F3B-A027-452F-B1CC-19A5D26532E6</gtr:id><gtr:title>Differential bioreactivity of neutral, cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cells.</gtr:title><gtr:parentPublicationTitle>Particle and fibre toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b37247973055fb50f821ed3fbcf1cdff"><gtr:id>b37247973055fb50f821ed3fbcf1cdff</gtr:id><gtr:otherNames>Ruenraroengsak P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1743-8977</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1ECDB86D-6EE2-4C77-A545-6A2C5D680982"><gtr:id>1ECDB86D-6EE2-4C77-A545-6A2C5D680982</gtr:id><gtr:title>Imaging single nanoparticle interactions with human lung cells using fast ion conductance microscopy.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f5c74f2f031a8194794fe50f22d63d5c"><gtr:id>f5c74f2f031a8194794fe50f22d63d5c</gtr:id><gtr:otherNames>Novak P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F89C7D52-89CD-4662-9C3F-4692EF6CC130"><gtr:id>F89C7D52-89CD-4662-9C3F-4692EF6CC130</gtr:id><gtr:title>Low-dose AgNPs reduce lung mechanical function and innate immune defense in the absence of cellular toxicity.</gtr:title><gtr:parentPublicationTitle>Nanotoxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/28f93d4746478fbcae028c97480cd1a5"><gtr:id>28f93d4746478fbcae028c97480cd1a5</gtr:id><gtr:otherNames>Botelho DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1743-5390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA34E121-9298-4EEA-A34A-2B17E89A0E32"><gtr:id>DA34E121-9298-4EEA-A34A-2B17E89A0E32</gtr:id><gtr:title>Static and Dynamic Microscopy of the Chemical Stability and Aggregation State of Silver Nanowires in Components of Murine Pulmonary Surfactant.</gtr:title><gtr:parentPublicationTitle>Environmental science &amp; technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f4d6b2748b5e3a6625b2410aec8863f4"><gtr:id>f4d6b2748b5e3a6625b2410aec8863f4</gtr:id><gtr:otherNames>Theodorou IG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0013-936X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/924377BA-8899-4A6B-BCA3-76F8BED14A8D"><gtr:id>924377BA-8899-4A6B-BCA3-76F8BED14A8D</gtr:id><gtr:title>Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles.</gtr:title><gtr:parentPublicationTitle>Nanotoxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b37247973055fb50f821ed3fbcf1cdff"><gtr:id>b37247973055fb50f821ed3fbcf1cdff</gtr:id><gtr:otherNames>Ruenraroengsak P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1743-5390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8EF475F2-AD52-4C79-BB79-2E846C479A2C"><gtr:id>8EF475F2-AD52-4C79-BB79-2E846C479A2C</gtr:id><gtr:title>Comparative study using spheres, rods and spindle-shaped nanoplatelets on dispersion stability, dissolution and toxicity of CuO nanomaterials.</gtr:title><gtr:parentPublicationTitle>Nanotoxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b998d5ad908bcd57100e891cbd46f868"><gtr:id>b998d5ad908bcd57100e891cbd46f868</gtr:id><gtr:otherNames>Misra SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1743-5390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C73333E-6684-4842-AE64-AF3AB72646BE"><gtr:id>3C73333E-6684-4842-AE64-AF3AB72646BE</gtr:id><gtr:title>Spectral monitoring of surfactant clearance during alveolar epithelial type II cell differentiation.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/38aba7a5927c2f9177f8acc5c9684e24"><gtr:id>38aba7a5927c2f9177f8acc5c9684e24</gtr:id><gtr:otherNames>Swain RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/325B57F9-9A4D-4F1B-B1BE-B919A0D07D97"><gtr:id>325B57F9-9A4D-4F1B-B1BE-B919A0D07D97</gtr:id><gtr:title>New perspectives in nanomedicine.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/150f806bb046b0177e79fb5069eb26f7"><gtr:id>150f806bb046b0177e79fb5069eb26f7</gtr:id><gtr:otherNames>Thorley AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86456AE4-E9A3-4910-965C-0FDBA3F597C4"><gtr:id>86456AE4-E9A3-4910-965C-0FDBA3F597C4</gtr:id><gtr:title>Inhalation of silver nanomaterials--seeing the risks.</gtr:title><gtr:parentPublicationTitle>International journal of molecular sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f4d6b2748b5e3a6625b2410aec8863f4"><gtr:id>f4d6b2748b5e3a6625b2410aec8863f4</gtr:id><gtr:otherNames>Theodorou IG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1422-0067</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B5D163E-848C-4FF5-90C2-B257B8BDD6BA"><gtr:id>2B5D163E-848C-4FF5-90C2-B257B8BDD6BA</gtr:id><gtr:title>Characterisation of carbon nanotubes in the context of toxicity studies.</gtr:title><gtr:parentPublicationTitle>Environmental health : a global access science source</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37fc8bcfa4534c542ba12e44637d0897"><gtr:id>37fc8bcfa4534c542ba12e44637d0897</gtr:id><gtr:otherNames>Berhanu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1476-069X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4E9B3364-C87F-4F61-8C9E-D35B9A1E3146"><gtr:id>4E9B3364-C87F-4F61-8C9E-D35B9A1E3146</gtr:id><gtr:title>Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c8cd50ec95868cf9c63d3e9b14a9d43"><gtr:id>9c8cd50ec95868cf9c63d3e9b14a9d43</gtr:id><gtr:otherNames>Kemp SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/693E828A-030C-4D96-8BA5-5AC448DE513C"><gtr:id>693E828A-030C-4D96-8BA5-5AC448DE513C</gtr:id><gtr:title>Adsorption of surfactant protein D from human respiratory secretions by carbon nanotubes and polystyrene nanoparticles depends on nanomaterial surface modification and size.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86d9463d3d3396906f17daa2dc96c263"><gtr:id>86d9463d3d3396906f17daa2dc96c263</gtr:id><gtr:otherNames>Marchetti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C1B997A4-40CB-44FD-8450-79D6F3A11CAB"><gtr:id>C1B997A4-40CB-44FD-8450-79D6F3A11CAB</gtr:id><gtr:title>In search of the fibrotic epithelial cell: opportunities for a collaborative network.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4adafc2a6d2256275be606b57ffc846"><gtr:id>b4adafc2a6d2256275be606b57ffc846</gtr:id><gtr:otherNames>Jenkins G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/00C6387D-09B0-41B2-98CF-05B6E8BEBC4D"><gtr:id>00C6387D-09B0-41B2-98CF-05B6E8BEBC4D</gtr:id><gtr:title>In vitro models of inhalation toxicity and disease. The report of a FRAME workshop.</gtr:title><gtr:parentPublicationTitle>Alternatives to laboratory animals : ATLA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e49e5cef6d01832920f4799239b7aa90"><gtr:id>e49e5cef6d01832920f4799239b7aa90</gtr:id><gtr:otherNames>B?ruB? K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0261-1929</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FCCF7499-1782-478A-97E1-8E6173151EF6"><gtr:id>FCCF7499-1782-478A-97E1-8E6173151EF6</gtr:id><gtr:title>Loss of Rab27 function results in abnormal lung epithelium structure in mice.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Cell physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf890a37068893be5c32d9547f000c16"><gtr:id>bf890a37068893be5c32d9547f000c16</gtr:id><gtr:otherNames>Bolasco G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0363-6143</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EE3E181B-54AE-4B8E-8CD3-99F09E4B841B"><gtr:id>EE3E181B-54AE-4B8E-8CD3-99F09E4B841B</gtr:id><gtr:title>Functional consequences for primary human alveolar macrophages following treatment with long, but not short, multiwalled carbon nanotubes.</gtr:title><gtr:parentPublicationTitle>International journal of nanomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d88a63fa9988b253df7b73295d2b5d6a"><gtr:id>d88a63fa9988b253df7b73295d2b5d6a</gtr:id><gtr:otherNames>Sweeney S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1176-9114</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82F36832-1C46-49A4-B513-CCD8BE02B1B5"><gtr:id>82F36832-1C46-49A4-B513-CCD8BE02B1B5</gtr:id><gtr:title>Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/150f806bb046b0177e79fb5069eb26f7"><gtr:id>150f806bb046b0177e79fb5069eb26f7</gtr:id><gtr:otherNames>Thorley AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9BCBE313-AECE-4397-B360-63A43520E22E"><gtr:id>9BCBE313-AECE-4397-B360-63A43520E22E</gtr:id><gtr:title>Pulmonary toxicity of instilled silver nanoparticles: influence of size, coating and rat strain.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/49042d76e0cb66d9aea9842afb8c625b"><gtr:id>49042d76e0cb66d9aea9842afb8c625b</gtr:id><gtr:otherNames>Seiffert J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A4C0F8B9-CB0F-45EA-8FF3-184CC7A989E2"><gtr:id>A4C0F8B9-CB0F-45EA-8FF3-184CC7A989E2</gtr:id><gtr:title>Induction and enhancement of platelet aggregation in vitro and in vivo by model polystyrene nanoparticles.</gtr:title><gtr:parentPublicationTitle>Nanotoxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bc9258bfbae02494f9f086975246e252"><gtr:id>bc9258bfbae02494f9f086975246e252</gtr:id><gtr:otherNames>Smyth E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1743-5390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05C714C5-25DD-46FB-BAB2-2BB27193F39D"><gtr:id>05C714C5-25DD-46FB-BAB2-2BB27193F39D</gtr:id><gtr:title>Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8264f3e245676159199c7659b0ef86cb"><gtr:id>8264f3e245676159199c7659b0ef86cb</gtr:id><gtr:otherNames>Mercer PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D2DCC13-A491-4EF2-8F2D-E8630EA90DDC"><gtr:id>1D2DCC13-A491-4EF2-8F2D-E8630EA90DDC</gtr:id><gtr:title>Inflammatory response and barrier properties of a new alveolar type 1-like cell line (TT1).</gtr:title><gtr:parentPublicationTitle>Pharmaceutical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e9e28928b1ba43b3692567086344e241"><gtr:id>e9e28928b1ba43b3692567086344e241</gtr:id><gtr:otherNames>van den Bogaard EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0724-8741</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6B35A53E-27B9-45E3-9B94-86E573BB716C"><gtr:id>6B35A53E-27B9-45E3-9B94-86E573BB716C</gtr:id><gtr:title>Modeling In Vivo Interactions of Engineered Nanoparticles in the Pulmonary Alveolar Lining Fluid.</gtr:title><gtr:parentPublicationTitle>Nanomaterials (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bef9b69a60d1340ef613abc598cd2e97"><gtr:id>bef9b69a60d1340ef613abc598cd2e97</gtr:id><gtr:otherNames>Mukherjee D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2079-4991</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/95C20B00-6BB1-48E0-BB8A-DA1CF5E641F6"><gtr:id>95C20B00-6BB1-48E0-BB8A-DA1CF5E641F6</gtr:id><gtr:title>Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/caf3d032b5e39560b0be5e4330259686"><gtr:id>caf3d032b5e39560b0be5e4330259686</gtr:id><gtr:otherNames>Sarkar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F87BB26-ECA9-469E-843B-F9E74B028740"><gtr:id>3F87BB26-ECA9-469E-843B-F9E74B028740</gtr:id><gtr:title>Induction of platelet aggregation after a direct physical interaction with diesel exhaust particles.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/67504e0de1f67df2ce86f0b0970eb889"><gtr:id>67504e0de1f67df2ce86f0b0970eb889</gtr:id><gtr:otherNames>Solomon A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E39DD412-7E66-452F-B41C-DFC8A705F719"><gtr:id>E39DD412-7E66-452F-B41C-DFC8A705F719</gtr:id><gtr:title>Avoiding artefacts during electron microscopy of silver nanomaterials exposed to biological environments.</gtr:title><gtr:parentPublicationTitle>Journal of microscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1661961c3e118f7f4e3b8856f64cecee"><gtr:id>1661961c3e118f7f4e3b8856f64cecee</gtr:id><gtr:otherNames>Chen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2720</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F50D0BC6-FD75-4DF2-85DA-2D02403090C3"><gtr:id>F50D0BC6-FD75-4DF2-85DA-2D02403090C3</gtr:id><gtr:title>Innate immune responses to bacterial ligands in the peripheral human lung--role of alveolar epithelial TLR expression and signalling.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/150f806bb046b0177e79fb5069eb26f7"><gtr:id>150f806bb046b0177e79fb5069eb26f7</gtr:id><gtr:otherNames>Thorley AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EC30F400-800E-4986-B2F5-D8D15C796101"><gtr:id>EC30F400-800E-4986-B2F5-D8D15C796101</gtr:id><gtr:title>Importance of the HIF pathway in cobalt nanoparticle-induced cytotoxicity and inflammation in human macrophages.</gtr:title><gtr:parentPublicationTitle>Nanotoxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d4ae62560c7f47dd9a0d1fe50275d9dc"><gtr:id>d4ae62560c7f47dd9a0d1fe50275d9dc</gtr:id><gtr:otherNames>Nyga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1743-5390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/87ADC68A-6F40-4E9F-A851-2CFD0EDE7F63"><gtr:id>87ADC68A-6F40-4E9F-A851-2CFD0EDE7F63</gtr:id><gtr:title>Assessment of cell line models of primary human cells by Raman spectral phenotyping.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/38aba7a5927c2f9177f8acc5c9684e24"><gtr:id>38aba7a5927c2f9177f8acc5c9684e24</gtr:id><gtr:otherNames>Swain RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE540768-FE41-488A-8F61-812C763D5FAD"><gtr:id>DE540768-FE41-488A-8F61-812C763D5FAD</gtr:id><gtr:title>High-resolution analytical electron microscopy reveals cell culture media-induced changes to the chemistry of silver nanowires.</gtr:title><gtr:parentPublicationTitle>Environmental science &amp; technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1661961c3e118f7f4e3b8856f64cecee"><gtr:id>1661961c3e118f7f4e3b8856f64cecee</gtr:id><gtr:otherNames>Chen S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-936X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9EC6645-3543-412B-BA81-4C410C54C7B4"><gtr:id>E9EC6645-3543-412B-BA81-4C410C54C7B4</gtr:id><gtr:title>An investigation of the carbon nanotube--Lipid interface and its impact upon pulmonary surfactant lipid function.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ee1bd9e49246b7f4db74cac7f7c44e7c"><gtr:id>ee1bd9e49246b7f4db74cac7f7c44e7c</gtr:id><gtr:otherNames>Melbourne J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D93420DC-CDCC-4455-B86F-5B12BF8EDE12"><gtr:id>D93420DC-CDCC-4455-B86F-5B12BF8EDE12</gtr:id><gtr:title>Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and type-II epithelial cells.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d88a63fa9988b253df7b73295d2b5d6a"><gtr:id>d88a63fa9988b253df7b73295d2b5d6a</gtr:id><gtr:otherNames>Sweeney S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41728F9C-5E1C-4A87-B6DF-42BB98C35CA0"><gtr:id>41728F9C-5E1C-4A87-B6DF-42BB98C35CA0</gtr:id><gtr:title>Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f3cbae0588e53c5e311dd0f99e5d9040"><gtr:id>f3cbae0588e53c5e311dd0f99e5d9040</gtr:id><gtr:otherNames>Medford AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D95F7EBA-AE02-449C-B585-C812A4F245FF"><gtr:id>D95F7EBA-AE02-449C-B585-C812A4F245FF</gtr:id><gtr:title>Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/47b5e216fa7a4c270fb0472360284ec9"><gtr:id>47b5e216fa7a4c270fb0472360284ec9</gtr:id><gtr:otherNames>Maher TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700926</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>